Craig Crews

Craig Crews is the John C. Malone Professor of Molecular, Cellular, and Developmental Biology; Chemistry; and Pharmacology at Yale University, a position held since 1995. They are the founder of Halda Therapeutics (2019–present) and Arvinas (2013–present) and serve as Executive Director of the Yale Center for Molecular Discovery (2003–present). They also co-founded Proteolix (2003–2009). Their education includes a Ph.D. in Biochemistry from Harvard University (1992–1995), a Cancer Research Institute Fellowship in Chemical Biology at Harvard (1987–1992), a DAAD Fellowship in Microbiology at the University of Tübingen (1986–1987), and a B.S. in Chemistry from the University of Virginia (1982–1986).